Business And Significant Accounting Policies (Details)	6 Months Ended
	Jun. 30, 2018 item
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of Approved Federal Drug Administration Therapies	3
Number of product candidate in active clinical development	1